Sotalol marketed for life-threatening arrhythmias.
D000284:Administration, Oral; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D013015:Sotalol / Q000008:administration & dosage / Q000627:therapeutic use*; D017180:Tachycardia, Ventricular / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D013015:Sotalol